Organogenesis Holdings Inc. ORGO Grant — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s grant — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s grant — revenue?
- Organogenesis Holdings Inc. (ORGO) reported grant — revenue of $978K in Q1 2026.
- What does grant — revenue mean?
- This metric represents the total revenue recognized from government or private research grants specifically allocated to the company's regenerative medicine development programs. It reflects the company's ability to secure non-dilutive funding to support innovation and clinical research activities within its specialized product segments. Tracking this revenue helps investors assess the external validation of the company's R&D pipeline and its success in leveraging external capital for product development.